PepGen is a Massachusetts-based biotechnology firm that develops and commercializes oligonucleotide therapies for the treatment of neuromuscular and neurologic diseases.
Business Model:
Revenue: $0
Employees: 11-50
Address: 245 Main St.
City: Cambridge
State: MA
Zip: 02142
Country: US
PepGen is a Massachusetts-based biotechnology firm that develops and commercializes oligonucleotide therapies for the treatment of neuromuscular and neurologic diseases.
Contact Phone:
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
5/6/2022
IPO Valuation:
$269M
Ticker Symbol:
PEPG
IPO Price:
$12/share
Amount Raised:
$108M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|